IP Library Assignment 030719/0225
Patent Assignment
Reel/Frame 030719/0225

Change of Name

Recorded: 2013-07-01 Pages: 4
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-04-01
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
CREATIVE CAMPUS MONHEIM, BUILDING 4865, ALFRED-NOBEL-STRABE 10, MONHEIM, 40789, GERMANY
Covered Properties (6)
Sulphimides as Protein Kinase Inhibitors
Patent: 7,943,629 →
Application: 11/759,479 →
Publication: US 2008/0058358
17BETA-Cyano-18A-Homo-19-Nor-Androst-4-Ene Derivative, Its Use and Medicaments Comprising the Derivative
Application: 12/137,122 →
Publication: US 2009/0048218
8-Beta-Substituted Estratrienes as Selectively Active Estrogens
Application: 12/171,424 →
Publication: US 2009/0029957
Novel 2-Substituted Thiazole-4-Carboxamide Derivatives, Their Preparation and Use as Pharmaceuticals
Patent: 7,897,626 →
Application: 12/330,696 →
Publication: US 2009/0149517
Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments
Patent: 8,841,311 →
Application: 13/054,582 →
Publication: US 2011/0166168
Transdermal Therapeutic System with Crystallization-Inhibiting Protective Film (Release Liner)
Patent: 8,557,279 →
Application: 13/225,660 →
Publication: US 2012/0082714
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →
Assignment of Assignor's Interest Nov 22, 2019
From: BAYER INTELLECTUAL PROPERTY GMBH
To: LUYE PHARMA SWITZERLAND AG
Reel/Frame 051088/0904 →